Literature DB >> 28756611

Expression of β-adrenergic receptor subtypes in human normal and dilated ureter.

Hailin Shen1, Zhipeng Chen2, Al-Dhabi Mokhtar1, Xiaojun Bi1, Guolin Wu1, Shide Gong1, Chuanyang Huang1, Shuai Li1, Shuqi Du3.   

Abstract

BACKGROUND: Ureter peristalsis is a basic physiological function regulated by myogenic and neurogenic factors. The distribution and function of β-adrenergic receptors (β-AR) in the human ureter remain unknown. The aim of this study was to investigate the expression of β-AR subtypes in the normal and dilated human ureter.
METHODS: The upper, middle, and lower segments of normal and dilated ureters were collected from patients undergoing surgery for carcinoma of the kidney and upper urinary tract and ureteral stenosis. The mucosa and muscular layers were separated. Expression of β1-AR, β2-AR, and β3-AR mRNA and protein levels were detected by real-time PCR, western blot, and immunohistochemistry.
RESULTS: In both mucosa and muscular layers, the mRNA and protein expressions of β1-AR, β2-AR, and β3-AR were lower in the dilated ureter compared with the normal ureter. β1-AR mRNA was significantly decreased (by 76.64%; P < 0.01) in the mucosa layer of the middle segment of the dilated ureter. β1-AR and β3-AR mRNA were significantly decreased (by 75.53 and 53.62%, respectively; P < 0.01) in the muscular layer of the lower segment of the dilated ureter. Similar findings were observed for protein expression.
CONCLUSIONS: The downregulation of β-ARs after ureter dilation, particularly for β1-AR and β3-AR in the muscular layer, suggests a potential compensatory mechanism involving increased contraction of the ureter to push urine through the obstruction. Thus, β-ARs may be a potential target for treatment of ureter obstruction.

Entities:  

Keywords:  Dilated ureter; Human; Normal ureter; Obstruction; β-adrenergic receptor

Mesh:

Substances:

Year:  2017        PMID: 28756611     DOI: 10.1007/s11255-017-1667-y

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  18 in total

Review 1.  [The electromotor unit of the upper urinary tract].

Authors:  P Hanke; R Bickeböller; A Mersdorf; D Jonas
Journal:  Helv Chir Acta       Date:  1992-10

2.  β-Adrenoceptor-Mediated Relaxation of Carbachol-Pre-Contracted Mouse Detrusor.

Authors:  Stefan Propping; Manja Newe; Kristina Lorenz; Manfred P Wirth; Ursula Ravens
Journal:  Urol Int       Date:  2015-01-30       Impact factor: 2.089

3.  Systemic and topical drug administration in the pig ureter: effect of phosphodiesterase inhibitors alpha1, beta and beta2-adrenergic receptor agonists and antagonists on the frequency and amplitude of ureteral contractions.

Authors:  H Danuser; R Weiss; D Abel; B Walter; G Scholtysik; D Mettler; U E Studer
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

4.  Involvement of cyclic AMP-dependent and -independent mechanisms in the relaxation of rat detrusor muscle via beta-adrenoceptors.

Authors:  Hisashi Uchida; Keiichi Shishido; Masanori Nomiya; Osamu Yamaguchi
Journal:  Eur J Pharmacol       Date:  2005-08-22       Impact factor: 4.432

5.  Beta-adrenoceptor subtypes in the ureteral smooth muscle of rats, rabbits and dogs.

Authors:  Y Tomiyama; K Hayakawa; K Shinagawa; M Akahane; Y Ajisawa; Y C Park; T Kurita
Journal:  Eur J Pharmacol       Date:  1998-07-10       Impact factor: 4.432

6.  Catecholamines relax detrusor through beta 2-adrenoceptors in mouse and beta 3-adrenoceptors in man.

Authors:  Melinda Wuest; Birgit Eichhorn; Marc O Grimm; Manfred P Wirth; Ursula Ravens; Alberto J Kaumann
Journal:  J Pharmacol Exp Ther       Date:  2008-09-26       Impact factor: 4.030

7.  Pharmacological characterization of beta-adrenoceptor subtypes mediating relaxation in porcine isolated ureteral smooth muscle.

Authors:  Isao Wanajo; Yoshitaka Tomiyama; Yoshinobu Yamazaki; Masami Kojima; Nobuo Shibata
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

8.  Comparison between CL-316243- and CGP-12177A-induced relaxations in isolated canine ureter.

Authors:  Yoshitaka Tomiyama; Makoto Murakami; Yoshinobu Yamazaki; Masami Kojima; Masuo Akahane
Journal:  Pharmacology       Date:  2003-07       Impact factor: 2.547

9.  Expression and functional role of β3 -adrenoceptors in the human ureter.

Authors:  Rikiya Matsumoto; Atsushi Otsuka; Takahisa Suzuki; Hitoshi Shinbo; Takuji Mizuno; Yutaka Kurita; Soichi Mugiya; Seiichiro Ozono
Journal:  Int J Urol       Date:  2013-01-29       Impact factor: 3.369

10.  Mucosa of murine detrusor impairs β2 -adrenoceptor-mediated relaxation.

Authors:  Stefan Propping; Manja Newe; Alberto J Kaumann; Manfred P Wirth; Ursula Ravens
Journal:  Neurourol Urodyn       Date:  2014-05-12       Impact factor: 2.696

View more
  3 in total

1.  The Efficacy of Mirabegron in Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta-Analysis.

Authors:  Dawei Cai; Guangzhu Wei; Peishan Wu; Yongjin Huang; Xuanyan Che; Yong Zhang; Zhongbao Zhou; Guangqi Kong
Journal:  Int J Clin Pract       Date:  2022-03-24       Impact factor: 3.149

Review 2.  Everything You Always Wanted to Know about β3-AR * (* But Were Afraid to Ask).

Authors:  Giorgia Schena; Michael J Caplan
Journal:  Cells       Date:  2019-04-16       Impact factor: 6.600

3.  Mirabegron attenuates porcine ureteral contractility via α1-adrenoceptor antagonism.

Authors:  Iris Lim; Russ Chess-Williams
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-04-21       Impact factor: 3.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.